» Articles » PMID: 32190737

QTc Interval Predicts Disturbed Circadian Blood Pressure Variation

Overview
Journal Open Med (Wars)
Specialty General Medicine
Date 2020 Mar 20
PMID 32190737
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The relationship between electrocardiographic evaluation and circadian blood pressure (BP) variation in young and middle-aged hypertensive patients remains unknown.

Methods: A total of 171 hypertensive patients were included in the study. First, patients were divided into a young and middle-aged group and an elderly group. The two groups were then separately classified into three subgroups on the basis of circadian variation of BP as dippers, non-dippers and reverse-dippers. The electrocardiographic evaluation was calculated from 12-lead electrocardiography (ECG).

Results: QTc intervals were shortest in the dippers and longest in the reverse-dippers in the young and middle-aged group (QTc dipper: 416.53±18.37ms; non-dipper: 438.30±29.71ms; reverse-dipper: 444.93±25.47ms; for dipper vs non-dipper, and dipper vs reverse-dipper P<0.05). QTc interval was found to be an independent risk factor for the non-dipper BP pattern (Odds ratio 1.049; 95% CI 1.01-1.089; P=0.012) and reverse-dipper BP pattern (Odds ratio 1.051; 95% CI 1.007-1.098; P=0.023) in young and middle-aged hypertensive patients. No significant differences in other ECG parameters were found among the three subgroups in the young and middle-aged group.

Conclusion: Our study suggested that QTc interval might serve as a risk factor for non-dipper BP pattern and reverse-dipper BP pattern in young and middle-aged hypertensive patients.

References
1.
Hermida R . Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project. Chronobiol Int. 2016; 33(7):906-36. DOI: 10.1080/07420528.2016.1181078. View

2.
Hermida R, Ayala D, Mojon A, Fernandez J . Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010; 27(8):1629-51. DOI: 10.3109/07420528.2010.510230. View

3.
Tisdale J, Jaynes H, Kingery J, Mourad N, Trujillo T, Overholser B . Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013; 6(4):479-87. PMC: 3788679. DOI: 10.1161/CIRCOUTCOMES.113.000152. View

4.
Casale P, Devereux R, Kligfield P, Eisenberg R, Miller D, Chaudhary B . Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol. 1985; 6(3):572-80. DOI: 10.1016/s0735-1097(85)80115-7. View

5.
Dekker J . The value of the heart-rate corrected QT-interval for cardiovascular risk stratification. Eur Heart J. 1999; 20(4):250-1. View